Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Regulatory Effect of Bee Venom on Methamphetamine-Induced Cellular Activities in Prefrontal Cortex and Nucleus Accumbens in Mice
Ji Seon SonYoung Chan JeongYoung Bae Kwon
著者情報
ジャーナル フリー HTML

2015 年 38 巻 1 号 p. 48-52

詳細
Abstract

Our previous studies demonstrated that subcutaneous injection of bee venom (BV) into the Zusanli (ST36) acupuncture point, namely BV acupuncture, dose-dependently prevents conditioned place preference (CPP) induced by repeated injection of methamphetamine (METH) in mice. To expand on our observations, the present study was designed to determine the suppressive mechanisms of BV acupuncture in the development of METH-induced CPP by evaluating the changes in expression of ΔFosB, phosphorylated extracellular signal-regulated kinase 1/2 (pERK), and phosphorylated calcium/calmodulin-dependent protein kinase type II (pCaMKII) in the prefrontal cortex (PFC) and nucleus accumbens (NAc) in mice. Pre-emptive treatment with BV at 30 min before repeated METH injection completely suppressed acquisition of CPP at the day 7 test session. METH-induced upregulation of ΔFosB and pERK in PFC and NAc was significantly reduced by BV pretreatment. Expression of pCaMKII was significantly elevated by METH in NAc and reduced in PFC. BV pretreatment reversed the changes of pCaMKII expression in PFC and NAc. These findings suggest that BV acupuncture may exert a suppressive effect on METH-induced addiction via regulation of signaling cascades of ΔFosB, ERK, and CaMKII in PFC and NAc.

Addiction to methamphetamine (METH) is an international public health problem. Acute administration of METH results in a sense of euphoria and hyperactivity in association with increased extracellular release of monoamine neurotransmitters, including dopamine, norepinephrine and serotonin.1,2) Chronic METH abuse produces several negative side effects, including dopaminergic nerve terminal toxicity, altered morphology in the central nervous systems and an increased risk of developing Parkinson’s disease.3) Nevertheless, exacerbating the problem of METH-induced neurotoxicity is the current lack of Food and Drug Administration (FDA)-approved pharmacotherapies for treating the negative health effects of METH abuse.4)

Numerous studies have been performed to evaluate the most effective therapeutic methods to treat METH addiction through the long-lasting prevention of relapse to METH use without side effect. Some of these studies have investigated needle acupuncture, which has been used to treat various drug addictions in humans. However, most studies revealed that needle acupuncture produces a significant but only partial therapeutic effect compared with the placebo control.5) Our recent studies firstly demonstrated that acupuncture with bee venom (BV), which is a potent peripheral stimulant that is dissolved in saline and administered into Zusanli acupuncture point (ST36), could dose-dependently reduce the hyperactivity induced by a single injection of METH as compared with other acupuncture points [Yinlingquan (SP9) and Xuanzhong (GB39)] or non-acupuncture point (tail base).6) This result indicated that BV injection into Zusanli acupuncture point was a potent method for the suppression of METH addiction. On the other hand, repeated METH (1 mg/kg) administration at days 1, 3 and 5 produced development of conditioned place preference (CPP) on day 7 (acquisition state). Following acquisition of METH for 6 d, CPP was completely gone at day 17 (extinction state). On day 18, the sub-effective dose of METH (0.1 mg/kg) re-increased CPP with similar level of acquisition stage (reinstatement state). We observed that pre-treatment of BV acupuncture before METH injection during acquisition state completely inhibited development of CPP in both acquisition state and reinstatement state, whereas single pre-treatment of BV acupuncture after acquisition state did not affect the development of CPP at reinstatement state.7) Although precise mechanisms of BV acupuncture in the development of CPP at acquisition state are still unclear, these results strongly indicate that pre-emptive treatment of BV acupuncture may be a promising way to support treatments for METH dependence. In this reason, present study was aimed to address inhibitory mechanism underlying pre-emptive BV acupuncture in the development of CPP by METH.

METH addicts may be related to neurological changes in the prefrontal cortex (PFC) and its glutamatergic projections to the nucleus accumbens (NAc). A recent study shows some initial characterization of the modifications of METH-induced intracellular signaling cascades and associated gene transcription factors in these regions of the brain. The development and expression of METH-induced locomotor sensitization and psychological changes accompanied increased levels of phosphorylated extracellular signal-regulated kinase 1/2 (pERK) in the brain areas.8,9) In contrast, the level of phosphorylated calcium/calmodulin-dependent protein kinase type II (pCaMKII), which has been implicated in the regulation of dopaminergic neurotransmission, decreased in brain regions after chronic administration of METH.1012) Moreover, it is notable that the increased level of ΔFosB, which is a long-lasting transcription factor, is involved in METH-induced neurotoxicity in the central nervous system.13) Our previous study revealed that a single METH injection significantly increased neuronal activation (Fos expression) in these brain regions, and this activation was regulated by BV acupuncture.6) As an extension of our findings, the current study was designed to determine the intracellular suppressive mechanisms of pre-emptive BV acupuncture in discrete brain areas, including the PFC and NAc, following repeated METH injection.

MATERIALS AND METHODS

Animals

Experiments were performed using male ICR mice (20–22 g). All experimental animals were purchased from the Daehan Biolink (Chungbuk, South Korea) and housed in colony cages with free access to food and water and maintained in a temperature- and light-controlled room (23±2°C, 12/12 h light/dark cycle with lights on at 08:00) for at least 1 week prior to the study. All of the methods used in the present study were approved by the Institute of Animal Care and Use Committee at Chonbuk National University and conform to NIH guidelines (NIH Publication No. 86-23, revised in 1985).

Procedure for Conditioned Place Preference

For place conditioning, eight identical polyvinyl chloride shuttle boxes (30 cm×20 cm×30 cm), each divided by a separator into two chambers of equal size (30 cm×20 cm×15 cm), were used. One chamber was black with a smooth floor and the other was white with a wire mesh floor. Each test animal received a pre-exposure test for 3 d before the experiment, in which they were allowed access to the entire apparatus for 15 min. The amount of time spent (s) in each chamber was monitored. On days 1, 3 and 5 mice were subcutaneously given METH (1 mg/kg) and then placed in the assigned chamber for 60 min. On days 2, 4 and 6, mice were given saline before being confined in the other chamber for 60 min. On the test day (day 7), the door separating the two chambers was opened again, and the mice were allowed free access to the entire apparatus for 15 min without any restriction. An acquisition test, in which the amount of time spent (s) in each chamber was recorded, was performed (Fig. 1A). The difference in seconds between the time spent in the drug-paired compartment in the post-conditioning test (day 7) and that spent in the same compartment in the pre-conditioning day (day 0) is a measurement of conditioned place preference (CPP, s) caused by the drug. The behavior of the mice was recorded by a video camera and analyzed by Smart-CS system set (Panlab, Barcelona, Spain).

Fig. 1. Experimental Schedule for the Induction of Methamphetamine (METH)-Induced Conditioned Place Preference (CPP) and Bee Venom (BV) Treatment in Mice (A)

Mice were subcutaneously injected with either saline (Sal) or BV (20 µL, 1 mg/mL) 30 min prior to METH injection. The pre-emptive treatment of BV acupuncture on METH-induced CPP in mice (B). *** p<0.001 as compared with that of the Sal–Sal group. ###p<0.001 as compared with that of the METH–Sal group. Each group included 8 mice. Data values are expressed as the mean±S.E.M.

Bee Venom Treatment

BV from Apis mellifera (Cat. No.: V3375, Sigma, St. Louis, MO, U.S.A.) was dissolved in a sterile saline solution at 1 mg/mL, which dose of BV produced most potent preventive effect on METH induced CPP as previously described.7) Twenty microliter of BV solution was bilaterally and subcutaneously administrated into the Zusanli acupuncture point (ST36) at 30 min prior to METH injection on days 1, 3 and 5, as previously described.6) ST36 is located 5 mm lower and lateral to the anterior tubercle of the tibia and it is the most potent and reliable acupuncture point in both mice and human addiction study.14,15) As a BV acupuncture control group, a vehicle control group received an injection of a corresponding volume of saline in same site.

Western Blotting

After the CPP test (on day 7), the mice were killed by decapitation and each brain region (prefrontal cortex; PFC, nucleus accumbens; NAc) was removed in less than 60 s and was quick-frozen on dry ice, weighed, and then stored at −80°C. Each brain sample was homogenized in buffer containing 1 M Tris (pH 7.5), 1% NP-40, 0.5 M ethylenediaminetetraacetic acid (EDTA) (pH 7.5), 50 mM ethylene glycol bis(2-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA), 1 M dithiothreitol, 1 M benzanidine and 0.1 M phenylmethylsulfonyl fluoride (PMSF). The total amount of protein in each sample was determined using the Bradford assay before loading the proteins into polyacrylamide gels. The homogenates (50 µg protein) were separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were then transferred to nitrocellulose membranes. After the blots had been washed with TBST (10 mM Tris–HCl [pH 7.6], 150 mM NaCl, and 0.05% Tween-20), the membranes were blocked with 5% skim milk for 1 h and then they were incubated with the appropriate primary antibodies for ΔFosB (1 : 500; Abcam, MA, U.S.A.), calcium/calmodulin-dependent protein kinase type II (CaMKII, 1 : 1000; Abcam), phosphorylated calcium/calmodulin-dependent protein kinase type II (pCaMKII, 1 : 500; Santa Cruz, CA, U.S.A.), extracellular signal-regulated kinase 1/2 (ERK, 1 : 1000, Cell Signaling Technologies, MA, U.S.A.), phosphorylated extracellular signal-regulated kinase 1/2 (pERK, 1 : 1000, Cell Signaling Technologies) and β-actin/α-tubulin (loading control; Sigma). The membranes were then washed, the primary antibodies were detected using the appropriate secondary immunoglobulin G conjugated to horseradish peroxidase, and the bands were subsequently visualized with enhanced chemiluminescence (Amersham Pharmacia Biotech, Uppsala, Sweden).

Data and Statistical Analysis

Data values were expressed as the mean±S.E.M. All data were analyzed using the commercially available software GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, U.S.A.). Statistical analysis was carried out using one-way ANOVA followed by Tukey’s multiple comparisons test.

RESULTS

The time spent in the drug-paired chamber (CPP score) was significantly higher in the group treated with repeated METH administration at days 1, 3 and 5 (METH–Sal group) as compared with the saline-injected group (Sal–Sal group) on day 7 (Fig. 1B). Similar to our previous finding,7) pre-emptive treatment with BV (20 µL with BV 1 mg/mL concentration) prior to METH injection (METH–BV group) completely suppressed the acquisition of CPP at the day 7 test session, as compared with the METH–Sal group [Fig. 1B, F(2, 15)=43.33, p<0.0001].

To be able to determine whether the BV altered the METH-induced neuronal activity of the PFC and NAc, brain tissues were obtained after CPP test. As compared with Sal–Sal group, METH–Sal group show significant elevation of ΔFosB in PFC, which was significantly reversed by pre-emptive treatment with BV [Figs. 2A, B, F(2, 6)=112.4, p<0.0001]. In the NAc, METH induced up-regulation of ΔFosB was significantly reversed by BV pretreatment [Figs. 2A, B, F(2, 6)=7.532, p=0.0231]. Although the levels of ERK expression both the PFC and NAc were not changed by METH administration, the levels of pERK were significantly increased by METH in both the PFC and NAc as compared with Sal–Sal group (Fig. 3A). The METH-induced elevation of pERK was significantly blocked by BV pre-treatment in both the PFC [F(2, 6)=22.62, p=0.0016] and NAc [F(2, 6)=100.3, p<0.0001], respectively (Figs. 3A, B). Although the level of CaMKII was not changed in both PFC and NAc, the level of pCaMKII was significantly upregulated by METH in the NAc and reduced in the PFC (Fig. 4A). The pre-emptive treatment with BV significantly reversed the METH-induced changes of pCaMKII in both the PFC [F(2, 6)=127.8, p<0.0001] and NAc [F(2, 6)=98.51, p<0.0001], respectively (Figs. 4A, B).

Fig. 2. Western Blotting Image (A) and Analysis Data (B) for the Changes in ΔFosB Expression in the Prefrontal Cortex (PFC) and Nucleus Accumbens (NAc) after the Injection of Saline (Sal), Methamphetamine (METH), and METH+Bee Venom (BV) Acupuncture at Day 7

*** p<0.001, * p<0.05 as compared with that of the Sal–Sal group. ###p<0.001, #p<0.05 as compared with that of the METH–Sal group. Each group included three independent experiments. Data values are expressed as the mean±S.E.M.

Fig. 3. Western Blotting Image (A) and Analysis Data (B) for the Changes in Extracellular Signal-Regulated Kinase 1/2 (ERK) and Phosphorylated ERK (pERK) Expression in the Prefrontal Cortex (PFC) and Nucleus Accumbens (NAc) after the Injection of Saline (Sal), Methamphetamine (METH), and METH+Bee Venom (BV) Acupuncture at Day 7

*** p<0.001, ** p<0.01 as compared with that of the Sal–Sal group. ###p<0.001, ##p<0.01 as compared with that of the METH–Sal group. Each group included three independent experiments. Data values are expressed as the mean±S.E.M.

Fig. 4. Western Blotting Image (A) and Analysis Data (B) for the Changes in Calcium/Calmodulin-Dependent Protein Kinase Type II (CaMKII) and Phosphorylated CaMKII (pCaMKII) Expression in the Prefrontal Cortex (PFC) and the Nucleus Accumbens (NAc) after the Injection of Saline (Sal), Methamphetamine (METH) and METH+Bee Venom (BV) Acupuncture at Day 7

*** p<0.001, * p<0.05 as compared with that of the Sal–Sal group. ###p<0.001 as compared with that of the METH–Sal group. Each group included three independent experiments. Data values are expressed as the mean±S.E.M.

DISCUSSION

Chronic exposure to addictive drugs such as cocaine, morphine or ethanol can up-regulate the expression of ΔFosB, in a region-specific manner in the brain.16) It is very likely that ΔFosB is an important trigger that connects various networks involved in the manifestations and maintenance of addiction.17) Present studies have demonstrated that METH significantly increases neuronal activity by increasing Fos and ΔFos expression in several brain areas as similar with our previous finding.6) Generally, ΔFosB is enhanced in the NAc and its target site (ventral pallidum) after repeated METH injection.18) In this study, repeated administration of METH caused profound enhancement of ΔFosB expression in the PFC and NAc, accompanying CPP. Pre-emptive treatment with BV acupuncture significantly attenuated the expression of ΔFosB in these brain areas and evoked CPP due to repeated METH exposure, suggesting that BV acupuncture has a potential suppressive effect on the development of METH-induced CPP, and that the underlying molecular mechanism of BV might be related to its regulatory effect in the PFC and NAc, as previously described.17)

It is well known that glutamatergic dysfunction may impact dopaminergic transmission, and ultimately lead to the emergence of psychosis in METH abuse.19) ERK, a member of the MAPK family, is linked to dopaminergic neurotransmission (probably via the dopamine D1 receptor) in the mesocorticolimbic system (i.e., PFC, NAc, and striatum) and behavioral responses to METH.8,20) A recent study demonstrated that enduring cognitive and neural deficits by METH exposure may be related to glutamate and dopamine efflux from the PFC to the NAc.21) Therefore, PFC is considered to mediate executive function and decision-making processes, and is therefore a key neuroanatomical region in addictive behaviors.22) Present study revealed that repeated METH exposure significantly increased the level of pERK in the PFC, and that pre-emptive treatment of BV acupuncture dramatically reversed the METH-induced ERK phosphorylation in the PFC. In support of a pivotal role of ERK phosphorylation in the PFC, some promising anti-addictive drugs have been shown to improve METH-induced behavioral changes through normalizing ERK phosphorylation in the PFC.8,23) In contrast, our previous6) and current studies show that single or chronic administration of METH significantly decreases CaMKII phosphorylation in the PFC and that this change was significantly reversed by either dopamine D1 receptor antagonist or N-methyl-D-aspartate receptor antagonist.11) The present study also revealed that BV acupuncture reversed METH-induced CaMKII de-phosphorylation in the PFC, suggesting a pivotal suppressive mechanism underlying METH addiction. Likewise, repeated METH administration selectively up-regulated the expression of intracellular calcium channel (inositol-1,4,5-triphosphate receptor type 1, IP3R-1) only in the NAc but not the PFC, accompanying METH-induced CPP and the activation of the dopamine D1 receptor,24) suggesting that calcium signaling-induced changes play a minor role in the METH-induced neuronal activation in the PFC as compared with the NAc.

The NAc, which controls psychomotor and reward behaviors, is an important interface within the limbic system and receives convergent projections from dopaminergic and glutamatergic terminals.25) The elevation of dopamine efflux in the NAc is essential to the development of METH addiction, which is mediated by the activation of calcium dependent kinases (CaMKII and protein kinase C) that can lead to dopamine transporter phosphorylation.10) Moreover, the up-regulation of intracellular calcium channel (IP3R-1) in the NAc is mediated through the activation of the dopamine D1 receptor during the development of METH-induced CPP.24) On the other hand, a dopamine D1 receptor antagonist or a selective MAPK kinase inhibitor significantly reverses the hyper-phosphorylation of ERK in the NAc evoked by METH-induced CPP, as well as the expression of CPP in METH-treated animals.10,20) Based on these results, it is reasonable to consider that the development of CPP, induced by METH, may be related to the activation of ERK and CaMKII via dopamine D1 receptors. In the present study, we observed that METH-induced CPP was accompanied by the activation of ERK and CaMKII phosphorylation in the NAc. Moreover, pre-emptive treatment of BV acupuncture completely inhibited METH-induced ERK and CaMKII activation. Therefore, it is assumed that the suppressive effect of BV acupuncture may be produced by its inhibitory effect on ERK and CaMKII signaling cascades in the NAc.

In conclusion, the present study demonstrated for the first time that the signaling pathway cascade including ΔFosB, ERK and CaMKII in the PFC and the NAc is crucial, at least in part, to the long-lasting neuro-adaptation induced by METH, which may be related to the suppressive effects of pre-emptive BV acupuncture. Although the mechanisms underlying BV acupuncture-induced improvements relating to the extracellular release of monoamine neurotransmitters in the brain have yet to be delineated, our results support the notion that BV acupuncture represents an effective intervention aimed at repairing brain dopaminergic abnormality caused by repeated METH exposure.

Acknowledgment

This work was supported by research funds of Chonbuk National University in 2012. This paper was also supported by the Ministry of Trade, Industry and Energy (MOTIE), the Korea Institute for Advancement of Technology (KIAT), and the Honam Institute for Regional Program Evaluation through the Leading Industry Development for Economic Region (R000153801-00197752).

Conflict of Interest

The authors declare no conflict of interest.

REFERENCES
 
© 2015 The Pharmaceutical Society of Japan
feedback
Top